ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Elanco Animal Health securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The class action lawsuit against Elanco alleges that the company made false and misleading statements regarding the safety and approval timelines of its products, Zenrelia and Credelio Quattro, which led to overstated business prospects [3] - Investors who purchased Elanco securities between November 7, 2023, and June 26, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][3] - The deadline to move the Court to serve as lead plaintiff is December 6, 2024, and a lead plaintiff acts on behalf of other class members in directing the litigation [1] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [2] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [2] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise in this area [2]